FloBio LLC
Developing a novel point-of-care precision diagnostic platform for the rapid assessment of bleeding & clotting risk in emergency, trauma critical care settings.
- Stage Prototype Ready
- Industry Medical Devices and Equipment
- Location Philadelphia, PA, USA
- Currency USD
- Founded August 2017
- Employees 5
- Incorporation Type LLC
- Website flobiollc.com
Company Summary
FloBio is pioneering a game changing point-of-care diagnostic that assesses blood clotting function in emergency critical care patients. Rapid analysis of flowing blood has the potential to precisely identify the presence & source of clotting problems. Early risk identification and personalized management within the critical decision making window can lead to fewer patient complications, improved clinical outcomes, and reduced healthcare costs.
Team
-
Jerri Ann, a full time FloBio CEO since July 2018, received degrees from The Wharton School & Washington University. With over 25 years of executive-level business leadership experience, she brings an exceptional track record & breadth & depth of experience across the product development & commercialization spectrum. With a passion for new product planning & building businesses, she has been instrumental in shaping company vision & operations.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.